Table 1 Proportions of patients alive in November 2011, of those who took part in the National Cancer Patient Experience Survey 2010, and response to the survey among those sampled
From: Risk factors for delay in symptomatic presentation: a survey of cancer patients
Alive November 2011 | Response to survey a | ||||
|---|---|---|---|---|---|
ICD-10 | Cancer type | n | (%) | n | (%) |
Included in the analysis of risk factors for delay in presentation | |||||
C43 | Malignant melanoma | 963 | (92.3) | 159 | (79.9) |
C50 | Breast (women) | 10,078 | (91.1) | 164 | (82.4) |
C67 | Bladder | 4,637 | (89.6) | 160 | (80.4) |
C92.1 | Chronic myeloid leukaemia | 218 | (89.3) | 159 | (79.5) |
C54 | Body of uterus | 865 | (87.6) | 158 | (79.4) |
C82–83 | Non-Hodgkin’s lymphoma | 1,730 | (87.5) | 161 | (80.9) |
C53 | Cervix | 287 | (85.2) | 133 | (67.2) |
C61 | Prostate | 3,489 | (84.1) | 170 | (85.0) |
C91.1 | Chronic lymphocytic leukaemia | 700 | (82.1) | 161 | (80.5) |
C64–66 | Kidney and ureter | 702 | (82.0) | 154 | (78.6) |
C19–20 | Rectum | 2,195 | (81.4) | 175 | (88.4) |
C18 | Colon | 3,039 | (80.0) | 166 | (84.3) |
C40–41, C49 | Sarcoma | 280 | (78.9) | 140 | (70.7) |
C90 | Myeloma | 1,695 | (78.8) | 150 | (76.1) |
C01–06 | Oral cavity | 370 | (77.4) | 161 | (81.7) |
Not included in the analysis of risk factors for delay in presentation | |||||
C91.0, C92.0 | Acute leukaemia | 477 | (68.1) | 154 | (80.2) |
C56 | Ovary | 927 | (65.3) | 152 | (77.2) |
C77–79 | Secondary cancer | 1,959 | (60.4) | 144 | (74.6) |
C16 | Stomach | 425 | (55.7) | 140 | (73.7) |
C15 | Oesophagus | 533 | (50.5) | 155 | (81.2) |
C34 | Lung | 1,230 | (48.3) | 142 | (77.2) |
C25 | Pancreas | 181 | (38.9) | 113 | (71.5) |
